Benvic, a PVC compounds and ecological biopolymers player, has acquired Luc & Bel, a plastics processor in the design and manufacture of complex medical components under Class 8 cleanroom conditions.

The acquisition has been enabled by Benvic’s owner Investindustrial, and allows Benvic to strengthen its Medical division – supplying manufacturing materials, services and products to the world’s medical and healthcare markets.

Benvic has been steadily building its medical company portfolio over the past 18 months. Last year, the company acquired Modenplast, a specialist in the extrusion of formulations, tubes and tubulars for medical use.  

Luc Mertens, CEO of Benvic, said: “We are very pleased to continue our medical growth strategy with Luc & Bel. PVC plays a fundamental role in all parts of this sector and that is why we are taking a significant stake in medical forward integration and preparing to launch Benvic Medical in support of all our businesses and their medical manufacturing services.

“At a time when the COVID-19 world is sorely in need of know-how, we at Benvic will bring our in-depth materials expertise to all kinds of medical solutions.

“We are also confident that Luc & Bel, with its highly technological and innovative business model, will provide great added value to our group and to our customers.’

Luca Ferrari, founder of Luc & Bel, remains CEO of the company and minority partner together with the rest of the management team.

Ferrari said: “We are thrilled to have joined the Benvic Group and all the new synergies that will follow on, together with a strengthening of Luc & Bel's international position.”

In the coming months Benvic Medical is set to roll out further details of all its technologies and capabilities in medical technology across the group - materials design and medical plastics processing, injection moulding, tubing and profile extrusion and other medical specialties.